Results 11 to 20 of about 43,566 (258)

Time spent at home among older adults with acute myeloid leukemia receiving azacitidine- or venetoclax-based regimens

open access: yesHaematologica, 2022
Time at home is a critically important outcome to adults with acute myeloid leukemia (AML) when selecting treatment; however, no study to date has adequately described the amount of time older adults spend at home following initiation of chemotherapy ...
Christopher E. Jensen   +7 more
doaj   +1 more source

Infuusiohoidot turvallisesti kotona – selvitys älykkään teknologian mahdollisuuksista

open access: yesFinnish Journal of eHealth and eWelfare, 2017
The purpose of the research project titled “Safety at Home and in Institutional Care: Utilizing remote monitoring and smart pump -technology in infusion care” was to identify the profile of patients, who require institutional care for infusion therapy ...
Eija Kivekäs   +6 more
doaj   +1 more source

The impact of the COVID-19 pandemic on Fabry Disease Patients: an examination of Mood Status, Therapy Adherence, and COVID-19 infection

open access: yesOrphanet Journal of Rare Diseases, 2022
Background Fabry disease (FD) is a rare metabolic disorder, in which a lifelong enzyme replacement therapy (ERT) constitutes the cornerstone of disease-specific therapy.
Cebrail Karaca   +9 more
doaj   +1 more source

Subcutaneous Furosemide in Heart Failure

open access: yesJACC: Basic to Translational Science, 2018
Parenteral diuretics form the cornerstone of decongestion in heart failure. However, parenteral therapy routinely requires emergency room or inpatient care. A novel buffered furosemide formulation with neutral pH was developed to offer “hospital-strength”
Domenic A. Sica, MD   +6 more
doaj   +1 more source

A clinician’s guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases

open access: yesAllergy, Asthma & Clinical Immunology, 2022
Immunoglobulin replacement therapy is the standard-of-care treatment for patients with primary immunodeficiency diseases who have impaired antibody production and function.
Kristin Epland   +2 more
doaj   +1 more source

Subcutaneous vitamin B12 administration using a portable infusion pump in cobalamin-related remethylation disorders: a gentle and easy to use alternative to intramuscular injections

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Cobalamin (cbl)-related remethylation disorders are a heterogeneous group of inherited disorders comprising the remethylation of homocysteine to methionine and affecting multiple organ systems, most prominently the nervous system and the bone ...
Amelie S. Lotz-Havla   +6 more
doaj   +1 more source

Perioperative diabetes insipidus: Report of two unusual cases

open access: yesJournal of Clinical and Translational Endocrinology Case Reports, 2022
Diabetes insipidus (DI) is a rare clinical condition in the postoperative period. Post-surgery polyuria is a common finding, as the body excretes the excessive fluid given during surgery.
Nissar Shaikh   +4 more
doaj   +1 more source

Clinic- and Hospital-Based Home Care, Outpatient Parenteral Antimicrobial Therapy (OPAT) and the Evolving Clinical Responsibilities of the Pharmacist

open access: yesPharmacy, 2020
Clinic- and hospital-based home care describes models of care where services commonly associated with hospital inpatient care are provided at the patient’s home or in an outpatient or community-based clinic.
Toni Docherty   +2 more
doaj   +1 more source

Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia

open access: yesInternational Journal of Infectious Diseases, 2015
Introduction: Outpatient parenteral antibiotic therapy (OPAT) has become established as a standard of care in most Australian hospitals to treat a variety of infections.
S. Subedi   +4 more
doaj   +1 more source

Real-Life Use of Levodopa/Carbidopa Intestinal Gel in Parkinson’s Disease According to Analysis of Pump Data

open access: yesJournal of Parkinson’s Disease, 2020
Background: Levodopa/carbidopa intestinal gel (LCIG) infusion is an efficacious treatment of motor and non-motor fluctuations in people with Parkinson’s disease (PD). Real-life use of the treatment is not previously studied.
Dag Nyholm, Malak Adnan, Marina Senek
doaj   +1 more source

Home - About - Disclaimer - Privacy